BLRX Forex News

BioLineRx Collaborates With GenFleet To Advance Motixafortide In Pancreatic Ductal Adenocarcinoma

Biopharmaceutical company BioLineRx Ltd. (BLRX) announced Monday that it has entered into a collaboration agreement with China-based peer GenFleet Therapeutics to advance Motixafortide through a randomized Phase 2b clinical trial in pancreatic ductal adenocarcinoma, or PDAC.

RTTNews | 914 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.04254	GBPUSD	1.25793	AUDUSD	0.62163
USDJPY	157.908	USDCAD	1.44144	USDCHF	0.90229